Inhibitor Therapeutics, Inc. (INTI) Shareholders’ equity 2013–2021
Inhibitor Therapeutics, Inc. (INTI) shareholders’ equity at each fiscal year-end, per SEC filings.
-$3.6MFY2021 · since FY2013: -$765,836 → -$3.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -$3.6M | -7.8% |
| FY2020 | -$3.4M | -32.8% |
| FY2019 | -$2.5M | -7924.0% |
| FY2018 | $32,351 | -80.6% |
| FY2017 | $166,563 | -97.6% |
| FY2016 | $7.0M | +1558.1% |
| FY2015 | $423,979 | +583.0% |
| FY2014 | $62,079 | +108.1% |
| FY2013 | -$765,836 | — |
Source: SEC XBRL filings · For reference only · Not investment advice